Gabriele Sarais

720 citations
7 papers · 505 indexed · h-index 7
Topics
Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers)Neuroendocrine Tumor Research Advances (3 papers)Peptidase Inhibition and Analysis (2 papers)
Partner nations
ItalyFranceUnited States

In The Last Decade

Gabriele Sarais

7 papers receiving 494 citations

Peers

Gabriele Sarais
Comparison fields: 5 of 40
  • Molecular Biology 466
  • Nephrology 137
  • Genetics 129
  • Oncology 119
  • Epidemiology 94
Replace Richa Manwani with:
Richa Manwani United Kingdom
Lisa Rannigan United Kingdom
Mark Offer United Kingdom
Karen Wells United States
Hugh J. B. Goodman United Kingdom
Ernesto Anesi Italy
M Hasib Sidiqi United States
Darren Foard United Kingdom
Xianghua Huang China
Loren Herrera Hernandez United States
Gabriele Sarais relative to Richa Manwani United Kingdom Richa Manwani's profile →
Citations per field
00.5×10×15×20×25×
Richa Manwani · 1×
Citations per year

Countries citing papers authored by Gabriele Sarais

Since Specialization
Citations

This map shows the geographic impact of Gabriele Sarais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriele Sarais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriele Sarais more than expected).

Fields of papers citing papers by Gabriele Sarais

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriele Sarais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriele Sarais. The network helps show where Gabriele Sarais may publish in the future.

Co-authorship network of co-authors of Gabriele Sarais

This figure shows the co-authorship network connecting the top 25 collaborators of Gabriele Sarais. A scholar is included among the top collaborators of Gabriele Sarais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabriele Sarais. Gabriele Sarais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 18
2 32
3 23
4 48
5 160
6 36
7 188

About Gabriele Sarais

Gabriele Sarais is a scholar working on Genetics, Hematology and Oncology, having authored 7 papers that have together received 505 indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (7 papers), Neuroendocrine Tumor Research Advances (3 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Nephrology (137 citations), Genetics (129 citations) and Hematology (88 citations). Gabriele Sarais has collaborated with scholars based in Italy, France and United States. Frequent co-authors include Giampaolo Merlini, Giovanni Palladini, Paola Russo, Laura Obici, Remigio Moratti, Riccardo Albertini, G.V. Melzi d’Eril, Andrea Foli, Francesca Lavatelli and Simona Casarini. Their work appears in journals such as Blood, Clinical Chemistry and Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026